Skip to content

IDEAYA Biosciences, Inc. IDYA Total Current Liabilities

Total Current Liabilities at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$19.16B-20.4%
Amgen logo
AmgenAMGN
$24.96B+8.5%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$14.33M-60.1%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$209M+8.9%
Erasca, Inc. logo
Erasca, Inc.ERAS
$26.66M+4.7%
Immunome logo
ImmunomeIMNM
$27.41M-11.0%

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.36B+104%
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s total current liabilities?
IDEAYA Biosciences, Inc. (IDYA) reported total current liabilities of $64.83M in Q1 2026.
How has IDEAYA Biosciences, Inc.'s total current liabilities changed year-over-year?
IDEAYA Biosciences, Inc.'s total current liabilities increased by 27.5% year-over-year, from $50.85M to $64.83M.
What is the long-term trend for IDEAYA Biosciences, Inc.'s total current liabilities?
Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s total current liabilities has grown at a 8.8% compound annual growth rate (CAGR), from $38.64M to $58.82M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.